MONOHYDRATE DE CIMETIDINE ET PROCEDE POUR SA PREPARATION

The invention relates to the new monohydrate of N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine (cimetidine), a histamine-H2 receptor antagonist which is called N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: KALMAN HARSANYI, GYORGY DOMANY, OSZKAR FUCHS, LAJOS TOLDY, GYORGY FEKETE, ENDRE KASZTREINER, BELA HEGEDUS, FERENC MORASZ, ANDRAS RADO, TIBOR LANG, ARPAD LAZAR, EVA CSONGOR, TIBOR BALOGH, JANOS BORVENDEG, JOZSEF REITER, TIBOR SOMOGYI ET MARGIT IGLOY, EPOUSE BIDLO
Format: Patent
Sprache:fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to the new monohydrate of N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine (cimetidine), a histamine-H2 receptor antagonist which is called N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine H (cimetidine H) as well as to a process for the preparation of same, which comprises pouring a hot, homogeneous aqueous solution of N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine, optionally containing also methylamine, onto ice and separating the N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N''-cyanogu anidine monohydrate.